562 related articles for article (PubMed ID: 32423747)
1. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
[TBL] [Abstract][Full Text] [Related]
3. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
4. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
5. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
6. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
7. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
8. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
9. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
11. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.
Ak G; Metintas S; Taskın AN; Uzel Sener M; Soyler Y; Yilmaz M; Turna A; Akin Kabalak P; Bilaceroglu S; Koksal D; Yilmaz Demirci N; Sogukpinar O; Boga S; Ercelik M; Karadeniz G; Polat G; Guldaval F; Aka Akturk U; Yilmaz S; Ogan N; Yilmaz S; Esendagli D; Caglayan B; Zeybek A; Durmus Kocak N; Mutlu P; Atinkaya Baytemir C; Sarbay I; Yilmaz U; Metintas M
Lung; 2022 Dec; 200(6):807-815. PubMed ID: 36173482
[TBL] [Abstract][Full Text] [Related]
13. Improving the yield of diagnostic medical thoracoscopy for undiagnosed exudative pleural effusions using a rigid diagnostic algorithm.
Augustine J; Vijay A; Ramachandran D; Cleetus M; Nirmal AS; John S; Thomas S; Venkitakrishnan R
Int J Mycobacteriol; 2021; 10(4):405-410. PubMed ID: 34916459
[TBL] [Abstract][Full Text] [Related]
14. Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience.
Porcel JM; Civit C; Esquerda A; Salud A; Bielsa S
Arch Bronconeumol; 2017 Aug; 53(8):427-431. PubMed ID: 28237067
[TBL] [Abstract][Full Text] [Related]
15. Pleural lavage: a novel diagnostic approach for diagnosing exudative pleural effusion.
Mohamed KH; Mobasher AA; Yousef AI; Salah A; Ramadan MA; Emam AK; Alhayawan HM; Light RW
Lung; 2000; 178(6):371-9. PubMed ID: 11361060
[TBL] [Abstract][Full Text] [Related]
16. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
[TBL] [Abstract][Full Text] [Related]
18. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
